CFA
ARKG icon

Carroll Financial Associates’s ARK Genomic Revolution ETF ARKG Stock Holding History

Carroll Financial Associates’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$18.1M Sell
290,799
-897
-0.3% -$62K 0.96% 19
2021
Q3 		$21.8M Buy
291,696
+3,942
+1% +$331K 1.22% 18
2021
Q2 		$26.6M Buy
287,754
+5,197
+2% +$442K 1.51% 16
2021
Q1 		$25.1M Sell
282,557
-83,738
-23% -$8.31M 1.54% 15
2020
Q4 		$34.2M Sell
366,295
-83,265
-19% -$6.63M 2.27% 10
2020
Q3 		$28.6M Sell
449,560
-22,436
-5% -$1.31M 2.21% 10
2020
Q2 		$24.6M Buy
471,996
+320
+0.1% +$13.7K 2.05% 9
2020
Q1 		$14.8M Buy
471,676
+24,149
+5% +$807K 1.45% 15
2019
Q4 		$15M Buy
447,527
+95,886
+27% +$3.05M 1.19% 15
2019
Q3 		$10.4M Sell
351,641
-577
-0.2% -$18.8K 0.91% 17
2019
Q2 		$12.1M Buy
352,218
+2,560
+0.7% +$82.1K 1.06% 16
2019
Q1 		$11.5M Buy
349,658
+215,979
+162% +$6.38M 1.08% 18
2018
Q4 		$3.65M Buy
133,679
+97,784
+272% +$2.76M 0.41% 37
2018
Q3 		$1.2M Sell
35,895
-1,167
-3% -$36.9K 0.13% 108
2018
Q2 		$1.08M Buy
37,062
+6,560
+22% +$183K 0.11% 111
2018
Q1 		$785K Buy
30,502
+3,072
+11% +$83.2K 0.09% 126
2017
Q4 		$671K Buy
27,430
+11,950
+77% +$303K 0.07% 138
2017
Q3 		$415K Sell
15,480
-3,870
-20% -$91K 0.05% 177
2017
Q2 		$433K Buy
+19,350
New +$403K 0.05% 176

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Carroll Financial Associates's ARKG Position: Q4 2021 in Review

Carroll Financial Associates reduced its ARK Genomic Revolution ETF (ARKG) stake by 0.31% in Q4 2021, selling an estimated $62K and leaving 290,799 shares worth $18.1M. The position accounts for 0.96% of the portfolio, ranked #19.

Carroll Financial Associates first reported a position in ARKG in Q2 2017 and has held it in 19 quarters since. The position peaked at $34.2M in Q4 2020. 462 funds tracked by Wall St. Rank hold ARKG as of Q4 2021.

  • Carroll Financial Associates held 290,799 shares of ARK Genomic Revolution ETF worth $18.1M as of Q4 2021.
  • Carroll Financial Associates sold 897 ARK Genomic Revolution ETF shares in Q4 2021, an estimated $62K.
  • ARK Genomic Revolution ETF made up 0.96% of Carroll Financial Associates's portfolio in Q4 2021, its #19 holding.
  • Carroll Financial Associates first reported a position in ARK Genomic Revolution ETF in Q2 2017 and has held it in 19 quarters since.
  • Carroll Financial Associates's ARK Genomic Revolution ETF position peaked at $34.2M in Q4 2020.
  • 462 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.